Navigation Links
Tailored Hepatitis C Therapy May Cut Treatment Time in Half
Date:9/14/2011

By Madonna Behen
HealthDay Reporter

WEDNESDAY, Sept. 14 (HealthDay News) -- Patients infected with hepatitis C virus who have an early favorable response to a new three-drug regimen can be cured of the disease in half the normal time, a new study says.

In the multinational study, researchers showed that tailoring patients' treatment regimen to their response to the drugs, which is known as response-guided therapy, enabled many patients to cut treatment time in half and still achieve the same cure rates.

The paper was published Sept. 15 in the New England Journal of Medicine.

"Patients treated with this regimen who clear virus from their blood by 4 weeks of therapy and who remain virus negative after 12 weeks of therapy can shorten total treatment time from 48 to 24 weeks and have an excellent chance of hepatitis C virus cure," said the study's lead author, Dr. Kenneth E. Sherman, Gould Professor of Medicine and director of the digestive diseases division at the University of Cincinnati College of Medicine in Ohio.

The regimen combines peginterferon and ribavirin, two drugs that have been the standard of care for hepatitis C for more than a decade, with a recently approved hepatitis C medication called telaprevir, which is in a class of medications known as protease inhibitors. Telaprevir and another protease inhibitor called boceprevir were approved by the U.S. Food and Drug Administration in May. The drugs work by blocking an enzyme that the hepatitis C virus needs in order to replicate itself.

For the study, Sherman and his colleagues studied 540 men and women with hepatitis C who hadn't previously been treated for the disease. All of the patients started therapy by receiving the three-drug regimen for 12 weeks, followed by just the peginterferon-ribavirin combination.

After 20 weeks, 322 patients who had an extended rapid virologic response (meaning they had undetectable levels of the
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Tailored Therapy May Help More Stop Smoking
2. Shorter treatment with hepatitis C drug combination may be more beneficial, study shows
3. PATH B -- a comprehensive support program for patients diagnosed with chronic hepatitis B
4. Hepatitis Rates Soar Among IV Drug Users, Study Finds
5. INFORMS study: OR models of hepatitis B prove decisive in treating millions in US, China
6. Hepatitis B vaccination for health care students lags behind recommendations
7. Hepatitis C is transmitted by unprotected sex between HIV-infected men
8. P7 protein resistance mutations identified; represent drug targets for hepatitis C virus
9. Stepped-up vaccine series for hepatitis B is effective during pregnancy
10. New Drug Effectively Treats Hepatitis C
11. NEJM study: New drug represents breakthrough in treatment of hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Tailored Hepatitis C Therapy May Cut Treatment Time in Half
(Date:4/17/2014)... recent papers by a University of Colorado School ... develop treatments or vaccines for Dengue fever, West ... disease-causing flaviviruses. , Jeffrey S. Kieft, PhD, associate ... School of Medicine and an early career scientist ... recently published articles in the scholarly journals ...
(Date:4/17/2014)... Doctors who treat patients with a severe ... face an agonizing treatment decision. , The drug ... help relieve shortness of breath. But some patients ... cause potentially fatal complications following transplantation. , "It,s ... medical director of Loyola University Medical Center,s LAM ...
(Date:4/17/2014)... Medicine (BUSM) have discovered that the anti-seizure drug ... The findings, reported in the American Journal ... to more effective treatments for alcoholism. , Excessive ... causes of illness and death in the U.S. ... the productivity of workers and necessitating huge health ...
(Date:4/17/2014)... scientists and their partners have found that their proprietary ... transmission of multiple sexually transmitted infections (STIs) in both ... virus 2 (HSV-2), and human papillomavirus (HPV). The USAID-funded ... is effective against multiple strains of HIV, and has ... three viruses of at least eight hours prior to ...
(Date:4/17/2014)... found that India,s shocking rates of suicide are highest ... clinging to tiny smallholdings less than one hectare ... cotton and coffee, that are highly susceptible to global ... previous case studies that point to a crisis in ... of the nation,s economy during the 90s. Researchers say ...
Breaking Medicine News(10 mins):Health News:CU researchers discover target for treating dengue fever 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 2Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 3
... recent surge in,Methicillin-resistant Staphylococcus aureus (MRSA) cases have ... to health care,environments (HA-MRSA), the new community acquired ... and athletic settings(1).,Hospitals concerned about the growing incidence ... new technology that converts alcohol into a nonflammable,vapor, ...
... Nov. 2 RHEI Pharmaceuticals, Inc., a,fully integrated ... the China market, will be presenting, at the,Acumen ... on Monday,November 5, 2007 at 2:20 p.m., eastern. ... for any,company wishing to gain access to the ...
... BRIDGEWATER, Mass., Nov. 2 Pressure,BioSciences, Inc. (Nasdaq: ... Founder, President, and CEO, will present a corporate,overview at ... in New York City on Monday, November 5, 2007 ... at The New York Palace Hotel, New York,City. The ...
... defined as the capacity to perceive, comprehend and regulate one,s ... able to distinguish between emotions and use this information as ... important benefits of developing this type of intelligence is the ... face an ever changing social and cultural world more effectively. ...
... Instruments, Inc.,developer and manufacturer of Mikro-Tip(R) pressure transducer ... of its MPVS,Ultra(TM) P-V system for both small ... simultaneously and continuously measures high-fidelity,left ventricular pressure and ... in size from transgenic mice to domestic livestock. ...
... SEATTLE, Nov. 2 Dendreon Corporation (Nasdaq:,DNDN) will release its ... will host a conference call at 1:30,p.m. PT; 4:30 p.m. ... Access to the discussion may be obtained as follows: ... PT Date: November 15, 2007 ...
Cached Medicine News:Health News:Biomist Inc.: Health Officials Discover New Technology to Kill Superbug MRSA 2Health News:Pressure BioSciences to Present at the Rodman & Renshaw BioFin 9th Annual Healthcare Conference in New York City on November 5th 2Health News:Emotional Intelligence and the use of tobacco and cannabis 2Health News:Millar Instruments Launches Complete Pressure-Volume System for Large and Small Animal Models 2Health News:-Dendreon to Hold Conference Call on Thursday, November 15, 2007 at 4:30 PM ET- 2
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... its Symphony® CGM System as a non-invasive, wireless continuous ... Doman , Executive Chairman and Interim CEO of Echo ... Tenth Annual Equity Conference. Mr. Doman ...
(Date:1/15/2014)... NEW YORK , Jan. 15, 2014 ... research report is available in its catalogue: ... - India Drug Forecast and Market Analysis ... PharmaPoint: Atopic Dermatitis - India ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a leading ... of severely obese patients, today announced initial results ... selective inhibitor of methionine aminopeptidase 2 (MetAP2), in ... of genetic obesity.  These results showed improvements in ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
... Calif., May 5, 2011 Rigel Pharmaceuticals, Inc. (Nasdaq: ... chief financial officer, is scheduled to present a company overview ... in Las Vegas on Tuesday, May 10th at 10:00 a.m. ... The presentation will be webcast live and can be accessed ...
... May 5, 2011 Rochester Medical Corporation (NASDAQ: ... ended March 31, 2011. The Company reported record ... for the second quarter of last year.  It also reported ... to net loss of ($351,000) or ($0.03) per diluted share ...
Cached Medicine Technology:Rochester Medical Reports Second Quarter Results 2Rochester Medical Reports Second Quarter Results 3Rochester Medical Reports Second Quarter Results 4Rochester Medical Reports Second Quarter Results 5Rochester Medical Reports Second Quarter Results 6Rochester Medical Reports Second Quarter Results 7Rochester Medical Reports Second Quarter Results 8Rochester Medical Reports Second Quarter Results 9Rochester Medical Reports Second Quarter Results 10
... The PalmScan A2000 A-Scan [i.e., PalmScan A2000] ... biometer, which incorporates A-mode pulsed-echo ultrasound,technology, and ... the axial length (AL), anterior,chamber depth (ACD), ... This PalmScan A2000,device is also intended for ...
... TOX/See™ is a 1-step, hand-held, point-of-care device for ... in human urine. The TOX/See device can ... abused drugs in 3 to 8 minutes and ... TOX/See cassette is individually packaged to maximize convenience ...
... device for the qualitative detection of drug or ... device can detect up to nine of the ... minutes and requires only a few drops of ... maximize convenience and ease of use. TOX/See features ...
... device for the qualitative detection of drug or ... device can detect up to nine of the ... minutes and requires only a few drops of ... maximize convenience and ease of use. TOX/See features ...
Medicine Products: